Amarox KSA
Abdullah Alzomaie is a pharmacist with 15 years of experience in the pharmaceutical sector within the Middle East. Currently serving as a Board Member at the Pharmaceutical Industry Association and Chief Executive Officer at Saudi Amarox since May 2018, Abdullah has held various regulatory affairs and scientific roles, including Director of Scientific Office and Regulatory Affairs at Neopharma L L C and AJA Pharmaceutical Industries Co. Ltd. Previous experience includes consulting for Sanofi and Boehringer Ingelheim and managerial positions focused on regulatory affairs and governmental sector management at Saudi Tadawi Healthcare Company and Mediserv KSA. Abdullah holds a Bachelor’s degree in Pharmacy from King Saud University and a finance certificate from Prince Mohammed Bin Salman College of Business & Entrepreneurship. Currently, Abdullah operates as a freelance consultant specializing in business development and regulatory affairs.
This person is not in any teams
This person is not in any offices
Amarox KSA
Saudi Amarox is fast emerging as a trusted name for manufacturing, marketing and supply of best-in-class generics to the world with special emphasis on serving the unmet needs of the Middle Eastern Region. Based out of Saudi Arabia. Saudi Amarox is committed to emphasize on Quality & Access for transforming health and lives of people in Middle East region. Backed by highly qualified resources, strong global partnerships, state-of-the-art manufacturing facility, and well-entrenched distribution network we have effectively positioned ourselves to grow within and beyond the boundaries of KSA.